Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are currently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $15.18.
Several equities analysts have commented on IAS shares. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Scotiabank began coverage on shares of Integral Ad Science in a report on Thursday, December 5th. They issued a “sector perform” rating and a $10.00 price target for the company. Craig Hallum reduced their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Piper Sandler decreased their price target on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a report on Wednesday, November 13th. Finally, Oppenheimer dropped their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, November 13th.
View Our Latest Report on Integral Ad Science
Insiders Place Their Bets
Hedge Funds Weigh In On Integral Ad Science
Several institutional investors have recently made changes to their positions in IAS. Point72 DIFC Ltd purchased a new position in Integral Ad Science during the 3rd quarter valued at about $41,000. nVerses Capital LLC purchased a new position in Integral Ad Science during the third quarter valued at approximately $45,000. Quantbot Technologies LP bought a new position in Integral Ad Science in the third quarter worth approximately $106,000. XTX Topco Ltd purchased a new stake in Integral Ad Science during the second quarter worth $113,000. Finally, Edgestream Partners L.P. bought a new stake in Integral Ad Science during the 2nd quarter valued at $125,000. Hedge funds and other institutional investors own 95.78% of the company’s stock.
Integral Ad Science Trading Up 4.9 %
Shares of Integral Ad Science stock opened at $10.20 on Thursday. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm has a market cap of $1.66 billion, a price-to-earnings ratio of 51.00, a PEG ratio of 1.46 and a beta of 1.46. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53. The business has a 50-day moving average price of $10.97 and a 200-day moving average price of $10.79.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.09) EPS. Equities research analysts anticipate that Integral Ad Science will post 0.26 EPS for the current fiscal year.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Stories
- Five stocks we like better than Integral Ad Science
- How Investors Can Find the Best Cheap Dividend Stocks
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Are Trending Stocks? Trending Stocks Explained
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.